Matters of legal in nature including licensing, intellectual property, and lawsuits.
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in the natural course of the disease The FDA approved Evrysdi in August 2020 as the first and only at home SMA treatment... Read more
Companion diagnostic can help guide treatment decisions in cases of NSCLC SANTA CLARA, Calif., February 22, 2021 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC 22C3 pharmDx assay for expanded use in patients with non-small cell lung cancer (NSCLC). PD-L1 IHC 22C3... Read more
Redwood City, California, and Hilden, Germany, February 18, 2021 – QIAGEN today announced the launch of the QIAGEN Digital Insights Partnership program for genomic vendors to leverage QIAGEN’s genomic content and analysis leadership to expand customer access and deliver extended genomic solutions for scientists and clinicians. The first group of five new partnerships involves DNAnexus,... Read more
WALTHAM, Mass., Feb. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. Thermo Fisher won across... Read more
Companies join forces in cell therapy applications and commercial-scale manufacturing WALTHAM, Mass., Feb. 3, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive commercial access to Thermo Fisher’s Gibco CTS Dynabeads CD3/CD28. The agreement will support the clinical... Read more
J&X Technologies to pay Agilent more than $1.25 million in damages for “willful and malicious” theft of Agilent trade secrets SANTA CLARA, Calif., February 01, 2021 Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The court victory... Read more
January 28, 2021 BioTek Instruments, an Agilent Technologies, Inc., company, announces that it was granted a patent by the United States Patent and Trademark Office for the Automated Media Exchange (AMX) module for the MultiFlo FX Multi-Mode Dispenser. In cell biology workflows, the automated MultiFlo FX with AMX module enables hands-free, gentle, and highly consistent media exchanges and washing... Read more
This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of... Read more
Jan 21, 2021 SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company has received the CE-IVD mark for its Advanta™ Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.... Read more